AZTA Azenta Inc

USD 57.77 4.33 8.102544999999999
Icon

Azenta Inc (AZTA) Stock Analysis and Price Targets

COMMON STOCK | Medical Instruments & Supplies | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 57.77

+4.33 (+8.10)%

USD 2.88B

0.43M

USD 68.00(+17.71%)

N/A

Icon

AZTA

Azenta Inc (USD)
COMMON STOCK | NSD
USD 57.77
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.88B

N/A

USD 57.77

Azenta Inc (AZTA) Stock Forecast

Show ratings and price targets of :
USD 68.00
(+17.71%)

Based on the Azenta Inc stock forecast from 7 analysts, the average analyst target price for Azenta Inc is USD 68.00 over the next 12 months. Azenta Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Azenta Inc is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, Azenta Inc’s stock price was USD 57.77. Azenta Inc’s stock price has changed by +8.20% over the past week, +1.94% over the past month and +26.27% over the last year.

No recent analyst target price found for Azenta Inc
No recent average analyst rating found for Azenta Inc

Company Overview Azenta Inc

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segme...Read More

https://www.azenta.com

200 Summit Drive, Burlington, MA, United States, 01803

3,400

September

USD

USA

Adjusted Closing Price for Azenta Inc (AZTA)

Loading...

Unadjusted Closing Price for Azenta Inc (AZTA)

Loading...

Share Trading Volume for Azenta Inc Shares

Loading...

Compare Performance of Azenta Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AZTA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Azenta Inc (Sector: Medical Instruments & Supplies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ISRG
Intuitive Surgical Inc +6.11 (+1.34%) USD161.39B 78.18 59.92

ETFs Containing AZTA

Symbol Name AZTA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Azenta Inc (AZTA) Stock

Based on ratings from 7 analysts Azenta Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 6 buy, sell and 5 hold ratings.

Unfortunately we do not have enough data on AZTA's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for AZTA is USD 68.00 over the next 12 months. The maximum analyst target price is USD 79 while the minimum anlayst target price is USD 53.

AZTA stock's Price/Earning ratio is 1.57. Our analysis grades AZTA stock's Price / Earning ratio at A. This means that AZTA stock's Price/Earning ratio is above 4.000000000000004% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange. Based on this AZTA may be undervalued for its sector.

The last closing price of AZTA's stock was USD 57.77.

The most recent market capitalization for AZTA is USD 2.88B.

Based on targets from 7 analysts, the average taret price for AZTA is projected at USD 68.00 over the next 12 months. This means that AZTA's stock price may go up by +17.71% over the next 12 months.

We can't find any ETFs which contains Azenta Inc's stock.

As per our most recent records Azenta Inc has 3,400 Employees.

Azenta Inc's registered address is 200 Summit Drive, Burlington, MA, United States, 01803. You can get more information about it from Azenta Inc's website at https://www.azenta.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...